GNLX
GENELUX Corp
Pharmaceutical PreparationsNasdaq<br>Emerging growth company
Total Trades
64
Buys
10
Sells
48
Largest Trade
N/A
Insiders
14
Institutional Funds
61
Inst. Value
$1M+
Activist Filings
6
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Thomas John | Director | SELL | $15K–$50K | 10K | $2.90 | Mar 4, 2026 |
| Yu Yong | SVP | SELL | $15K–$50K | 4K | $3.82 | Dec 12, 2025 |
| Zindrick Thomas | President and CEO | SELL | $50K–$100K | 17K | $3.86 | Dec 12, 2025 |
| Cappello Joseph | Chief Technical Of… | SELL | $1K–$15K | 4K | $3.88 | Dec 12, 2025 |
| Smalling Ralph | Head of Regulatory | SELL | $1K–$15K | 2K | $3.75 | Dec 10, 2025 |
| Thomas John | Director | SELL | $50K–$100K | 10K | $5.00 | Dec 3, 2025 |
| Ryder Sean | General Counsel | SELL | $1K–$15K | 4K | $2.92 | May 13, 2025 |
| Zindrick Thomas | President and CEO | SELL | $15K–$50K | 11K | $2.92 | May 13, 2025 |
| Yu Yong | VP | SELL | $15K–$50K | 6K | $2.92 | May 13, 2025 |
| Cappello Joseph | VP | SELL | $1K–$15K | 5K | $2.92 | May 13, 2025 |
| Smalling Ralph | Head of Regulatory | SELL | $1K–$15K | 1K | $2.92 | May 13, 2025 |
| Tyree James L | Director | SELL | $1K–$15K | 3K | $2.46 | Dec 31, 2024 |
| Szalay Aladar | 10% Owner | SELL | $500K+ | 266K | $2.09 | Aug 30, 2024 |
| Szalay Aladar | 10% Owner | SELL | $100K–$500K | 92K | $2.19 | Aug 27, 2024 |
| Tyree James L | Director | BUY | N/A | 6K | — | Jun 8, 2024 |
| Smither John W | Director | BUY | N/A | 6K | — | Jun 8, 2024 |
| Thomas John | Director | BUY | N/A | 3K | — | Jun 8, 2024 |
| Mirabelli Mary | Director | BUY | N/A | 8K | — | Jun 8, 2024 |
| Yu Yong | VP | BUY | N/A | 3K | — | Jun 8, 2024 |
| Zindrick Thomas | President and CEO | BUY | N/A | 200K | — | Jun 8, 2024 |
| Smalling Ralph | Head of Regulatory | BUY | N/A | 1K | — | Jun 8, 2024 |
| Ryder Sean | General Counsel | BUY | N/A | 10K | — | Jun 8, 2024 |
| Zak Lourie S. | CFO | BUY | N/A | 31K | — | Jun 8, 2024 |
| Szalay Aladar | 10% Owner | SELL | $100K–$500K | 60K | $3.23 | May 1, 2024 |
| Szalay Aladar | 10% Owner | SELL | $100K–$500K | 44K | $3.51 | Apr 24, 2024 |
| Szalay Aladar | 10% Owner | SELL | $100K–$500K | 71K | $3.59 | Apr 18, 2024 |
| Yu Yong | VP | SELL | $100K–$500K | 19K | $10.26 | Nov 22, 2023 |
| Yu Yong | VP | SELL | $100K–$500K | 18K | $11.60 | Nov 21, 2023 |
| Szalay Aladar | 10% Owner | SELL | $100K–$500K | 6K | $19.40 | Oct 26, 2023 |
| Szalay Aladar | 10% Owner | SELL | $500K+ | 50K | $19.97 | Oct 25, 2023 |
| Yu Yong | VP | EXERCISE | $15K–$50K | 5K | $6.00 | Oct 25, 2023 |
| Yu Yong | VP | SELL | $50K–$100K | 5K | $19.11 | Oct 25, 2023 |
| Thomas John | Director | SELL | $50K–$100K | 3K | $20.71 | Oct 16, 2023 |
| Yu Yong | VP | EXERCISE | $15K–$50K | 5K | $6.00 | Oct 11, 2023 |
| Yu Yong | VP | SELL | $100K–$500K | 5K | $22.01 | Oct 11, 2023 |
| Szalay Aladar | 10% Owner | SELL | $100K–$500K | 14K | $24.93 | Oct 10, 2023 |
| Szalay Aladar | 10% Owner | SELL | $1M+ | 76K | $25.49 | Oct 4, 2023 |
| Szalay Aladar | 10% Owner | SELL | $100K–$500K | 14K | $24.41 | Sep 29, 2023 |
| Szalay Aladar | 10% Owner | SELL | $1M+ | 42K | $24.38 | Sep 27, 2023 |
| Yu Yong | VP | EXERCISE | $15K–$50K | 5K | $6.00 | Sep 27, 2023 |
| Yu Yong | VP | SELL | $100K–$500K | 5K | $23.56 | Sep 27, 2023 |
| Szalay Aladar | 10% Owner | SELL | $100K–$500K | 17K | $27.85 | Sep 25, 2023 |
| Yu Yong | VP | SELL | $100K–$500K | 6K | $27.96 | Sep 21, 2023 |
| Yu Yong | VP | EXERCISE | $15K–$50K | 6K | $6.00 | Sep 21, 2023 |
| Ryder Sean | General Counsel | SELL | $100K–$500K | 10K | $30.00 | Sep 21, 2023 |
| Ryder Sean | General Counsel | EXERCISE | $50K–$100K | 10K | $6.00 | Sep 21, 2023 |
| Szalay Aladar | 10% Owner | SELL | $1M+ | 62K | $24.92 | Sep 20, 2023 |
| Yu Yong | VP | SELL | $100K–$500K | 10K | $21.89 | Sep 19, 2023 |
| Yu Yong | VP | EXERCISE | $50K–$100K | 10K | $6.00 | Sep 19, 2023 |
| Thomas John | Director | SELL | $100K–$500K | 7K | $23.45 | Sep 19, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 61 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | 1.9M | $1M+ | SH |
| Bleichroeder LP | 714K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 315K | $1M+ | SH |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 303K | $1M+ | SH |
| Alyeska Investment Group, L.P. | 285K | $1M+ | SH |
| Global Retirement Partners, LLC | 217K | $500K+ | SH |
| Provident Wealth Management, LLC | 156K | $500K+ | SH |
| STATE STREET CORP | 146K | $500K+ | SH |
| MARSHALL WACE, LLP | 139K | $500K+ | SH |
| LPL Financial LLC | 134K | $500K+ | SH |
| LifeSteps Financial, Inc. | 118K | $500K+ | SH |
| AMG National Trust Bank | 75K | $100K–$500K | SH |
| Falcon Wealth Planning | 63K | $100K–$500K | SH |
| OMERS ADMINISTRATION Corp | 55K | $100K–$500K | SH |
| BARCLAYS PLC | 45K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 44K | $100K–$500K | SH |
| Richard Young Associates, Ltd. | 41K | $100K–$500K | SH |
| Point72 Asset Management, L.P. | 40K | $100K–$500K | SH |
| Hudson Bay Capital Management LP | 38K | $100K–$500K | SH |
| GOLDMAN SACHS GROUP INC | 38K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Nov 14, 2025
10.0%
4.2M shares
SC 13G/A · Jul 25, 2025
8.4%
3.2M shares
Highbridge Capital Management, LLC
SC 13G · Oct 25, 2024
6.8%
2.5M shares
SC 13G/A · Oct 22, 2024
9.9%
3.4M shares
SC 13G · Feb 2, 2024
15.7%
4.2M shares
SC 13G · Jun 20, 2023
8.7%
2.3M shares